Suppr超能文献

在大肠杆菌中表达重组非结构蛋白 1 用于日本脑炎病毒感染的早期检测。

Production of recombinant nonstructural 1 protein in Escherichia coli for early detection of Japanese encephalitis virus infection.

机构信息

Bioprocess Scale up Facility, Defence Research and Development Establishment, Jhansi Road, Gwalior-474002, India.

出版信息

Microb Biotechnol. 2012 Sep;5(5):599-606. doi: 10.1111/j.1751-7915.2012.00344.x. Epub 2012 Mar 27.

Abstract

Japanese encephalitis is a major public health problem in South-East Asia and Western Pacific countries. The recombinant nonstructural 1 (rNS1) protein of Japanese encephalitis virus is a potential diagnostic as well as vaccine candidate. Developments of cost-effective and simple culture media as well as appropriate culture conditions are generally favourable for large-scale production of recombinant proteins. The effects of medium composition and cultivation conditions on the production of rNS1 protein were investigated in shake flask culture as well as batch cultivation of Escherichia coli. Further, the fed-batch process was also carried out for high cell density cultivation (HCDC) of E. coli expressing rNS1 protein. Isopropyl-β-d-thiogalactopyranoside (IPTG) was used to induce the expression of rNS1 protein at ∼ 13 g dry cell weight per litre of culture. The final dry cell weight after fed-batch cultivation was ∼ 17 g l(-1) . The Inclusion bodies were isolated and purified through affinity chromatography to give a final product yield of ∼ 142 mg l(-1) . The reactivity of purified protein was confirmed by Western blotting and Enzyme linked immunosorbent assay. These results show that rNS1 protein may be used as a diagnostic reagent or for further prophylactic studies. This approach of producing rNS1 protein in E. coli with high yield may also offer promising method for production of other viral recombinant proteins.

摘要

日本脑炎是东南亚和西太平洋国家的一个主要公共卫生问题。日本脑炎病毒的重组非结构蛋白 1(rNS1)是一种有潜力的诊断和疫苗候选物。开发具有成本效益和简单的培养基以及适当的培养条件通常有利于重组蛋白的大规模生产。在摇瓶培养和大肠杆菌分批培养中,研究了培养基组成和培养条件对 rNS1 蛋白生产的影响。此外,还进行了分批补料培养,以实现表达 rNS1 蛋白的大肠杆菌高密度培养(HCDC)。异丙基-β-D-硫代半乳糖吡喃糖苷(IPTG)用于诱导 rNS1 蛋白的表达,在培养物中达到约 13 g 干细胞重量/升。补料分批培养后的最终干细胞重量约为 17 g/L。通过亲和层析分离和纯化包涵体,得到最终产物产量约为 142 mg/L。通过 Western blot 和酶联免疫吸附试验证实了纯化蛋白的反应性。这些结果表明,rNS1 蛋白可用作诊断试剂或进一步的预防性研究。这种在大肠杆菌中高产生产 rNS1 蛋白的方法也可能为生产其他病毒重组蛋白提供有前途的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b249/3815872/c0df6938701c/mbt0005-0599-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验